Mirae Asset Global Investments
LENZ

Mirae Asset Global Investments’s LENZ Therapeutics LENZ Stock Holding History

Mirae Asset Global Investments’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.96K Sell
1,402
-230
-14% -$1.85K ﹤0.01% 1591
2026
Q1 		$14.9K Buy
1,632
+112
+7% +$1.57K ﹤0.01% 1461
2025
Q4 		$24.3K Buy
1,520
+417
+38% +$12.2K ﹤0.01% 1511
2025
Q3 		$51.4K Buy
1,103
+16
+1% +$588 ﹤0.01% 1335
2025
Q2 		$31.9K Buy
1,087
+139
+15% +$3.78K ﹤0.01% 1323
2025
Q1 		$24.3K Buy
948
+32
+3% +$788 ﹤0.01% 1369
2024
Q4 		$28.7K Buy
+916
New +$27.9K ﹤0.01% 1366

Other funds holding LENZ

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return

Mirae Asset Global Investments's LENZ Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its LENZ Therapeutics (LENZ) stake by 14% in Q2 2026, selling an estimated $1.85K and leaving 1,402 shares worth $7.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Mirae Asset Global Investments first reported a position in LENZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $51.4K in Q3 2025. 23 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Mirae Asset Global Investments held 1,402 shares of LENZ Therapeutics worth $7.96K as of Q2 2026.
  • Mirae Asset Global Investments sold 230 LENZ Therapeutics shares in Q2 2026, an estimated $1.85K.
  • LENZ Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1591 holding.
  • Mirae Asset Global Investments first reported a position in LENZ Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's LENZ Therapeutics position peaked at $51.4K in Q3 2025.
  • 23 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.